Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdimFlu-V (2012-2013) Immunogenicity and Safety Study
NCT01759654Phase 3Completed
- Sponsor
- Adimmune
- Start
- Oct 2012
- Primary completion
- Dec 2012
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of influenza virus vaccine, split virion in influenza, sponsored by Adimmune. Started Oct 2012; status: completed.
02
Drugs
influenza virus vaccine, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01759654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01759654.